ANNDREA CAREY-BASKETT: Open Payments
NPI 1114205424 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 29 payments from 16 companies in 2025. Trend: 2023 $48 · 2024 $18 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $130 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Neos Therapeutics, LP | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Lundbeck LLC | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $25 |
| Corium, LLC | 1 | $24 |
Products named: HETLIOZ, REXULTI, Auvelity, Adzenys XR-ODT, UZEDY, VRAYLAR, FANAPT, INGREZZA.
Industry payments across NC — which companies pay providers there.
